Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Personalized iTBS in Real-World Clinical Settings for Schizophrenia [NA]

View source ↗

Summary

Recruitment is ongoing for a real-world study evaluating personalized intermittent theta-burst stimulation (iTBS) as a treatment for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intermittent Theta-Burst Stimulation (iTBS)

Snippet

Sponsor: Anhui Medical University | Conditions: Schizophrenia, Transcranial Magnetic Stimulation | NA | Status: RECRUITING